![The sights of Avalon Air Show 2025: Day Three [PHOTOS]](https://breakingdefense.com/wp-content/uploads/sites/3/2025/03/f-35-avalon-final-day-scaled-e1743079275404.jpg?#)
.jpg)
Sanofi's versatile Qfitlia scores FDA nod to enter crowded hemophilia market
Over the last three years, the FDA has approved six new drugs for hemophilia. And now the U.S. regulator has signed off on another, Sanofi’s Qfitlia, which sets itself apart as the only treatment for all types of hemophilia.
Over the last three years, the FDA has approved six new drugs for hemophilia. And now the U.S. regulator has signed off on another, Sanofi’s Qfitlia, which sets itself apart as the only treatment for all types of hemophilia.
